The weekly litigation news digest is live. Subscribe now

IP Verse

Supernus Pharmaceuticals, Inc. V. Creekwood Pharmaceuticals, Llc - 1:25cv00880

Supernus Pharmaceuticals, Inc. V. Creekwood Pharmaceuticals, Llc (Case No. 1:25cv00880), filed on Jul 15, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25cv00880
Filing Date
Jul 15, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Creekwood Pharmaceuticals, LLC -
Supernus Pharmaceuticals, Inc. -

Patents Involved

This case involves 6 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US12121523B2
-US9662338B2
-US11458143B2
-US9603853B2
-US9358204B2
-US11324753B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 16, 2025Summons Issued as to Creekwood Pharmaceuticals, LLC on 7/16/2025. (scs) (Entered: 07/16/2025)PACER Document
Jul 15, 2025Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliates BlackRock Inc. and The Vanguard Group for Supernus Pharmaceuticals, Inc., filed by Supernus Pharmaceuticals, Inc.. (scs) Modified on 7/16/2025 (nms). (Entered: 07/16/2025)PACER Document
Jul 15, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,358,204; 9,603,853; 9,662,338; 11,324,753 ; 11,458,143; 12,121,523. (scs) (Entered: 07/16/2025)PACER Document
Jul 15, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 5, 2025. Date of Expiration of Patent: 02/07/2033, 04/02/2035, 09/04/2029.Thirty Month Stay Deadline: 10/2/2028. (scs) (Entered: 07/16/2025)PACER Document
Jul 15, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 07/16/2025)PACER Document
Jul 15, 2025COMPLAINT filed against Creekwood Pharmaceuticals, LLC (Filing fee $ 405, receipt number ADEDC-4734833) - filed by Supernus Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-F, # 2 Civil Cover Sheet)(scs) (Entered: 07/16/2025)PACER Document